Table 2.
Characteristics | Overall | Controlled BP Group | Uncontrolled BP Group | P Value |
---|---|---|---|---|
No. (%) | 336 (100) | 71 (21.1) | 265 (78.9) | |
Mean fasting capillary glucose, g/L (SD) | 1.01 (0.40) | 0.89 (0.19) | 1.05 (0.43 | .004 |
Hyperglycemia, No. (%) | 48 (14.3) | 3 (4.2) | 45 (17.0) | .006 |
Dipstick abnormalities, No. (%) | ||||
Albuminuria | 132 (39.3) | 25 (35.2) | 107 (40.4) | .319 |
Hematuria | 50 (14.9) | 13 (18.3) | 37 (14.0) | .361 |
Leukocyturia | 27 (8.0) | 4 (5.6) | 23 (8.7) | .402 |
Mean serum creatinine, mg/L (SD) | 13.0 (10.4) | 11.7 (5.1) | 13.4 (11.4) | .229 |
Mean creatinine clearance, mL/min/1.73 m2 (SD) | ||||
MDRD | 71.0 (29.1) | 71.3 (31.1) | 70.9 (28.7) | .928 |
CG | 72.8 (35.0) | 68.0 (29.9) | 74.1 (36.2) | .193 |
CKD‐EPI | 70.1 (26.0) | 68.9 (21.7) | 70.5 (27.0) | .660 |
Abbreviations: BP, blood pressure; CG, Cockroft‐Gault; CKD‐EPI, Chronic Kidney Disease Epidemiology Collaboration; MDRD, Modification of Diet in Renal Disease; SD, standard deviation.